Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,867.50
-4.2683-0.23%
Number of Gainers:5
Number of Losers:14
Number of Flat:- -
PE:- -
High:1,871.60
Open:1,870.34
Low:1,853.56
Close:1,871.77
Volume:134.66M
Turnover:8.34B
Market Cap:1.52T
Float Cap:1.48T

Loading ...

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

TradingKey
·
Aug 28

Sector Update: Healthcare

MT Newswires Live
·
Aug 28

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

TIPRANKS
·
Aug 28

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

TIPRANKS
·
Aug 28

Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

TIPRANKS
·
Aug 28

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 28

Abbott Laboratories' Stroke Treatment Device Receives CE Mark

MT Newswires Live
·
Aug 27

Moderna Shares Down 3.6% After Co Announces $2 Bln Convertible Debt Plans

THOMSON REUTERS
·
Aug 27

Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement

TIPRANKS
·
Aug 27

Abbott - to Expand Amulet 360 Use Across Europe in Coming Weeks

THOMSON REUTERS
·
Aug 27

Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark

THOMSON REUTERS
·
Aug 27

Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke

THOMSON REUTERS
·
Aug 27

Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe

Reuters
·
Aug 27

Lakeland Fire + Safety Schedules Fiscal Q2 2027 Results Conference Call

Reuters
·
Aug 27

Moderna Falls After Unveiling $2 Bln Convertible Debt Plans

Reuters
·
Aug 27

Moderna to Sell $2 Billion Convertible Notes in Private Placement

Dow Jones
·
Aug 27

Moderna down 6% to $141.10 after $2B convertible note offering

TIPRANKS
·
Aug 27

Top Premarket Decliners

MT Newswires Live
·
Aug 27

Corvus Publishes Final Phase 1/1b Soquelitinib Data in Blood Supporting Phase 3 Relapsed/refractory PTCL Trial

Reuters
·
Aug 27

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1B T Cell Lymphoma Trial

THOMSON REUTERS
·
Aug 27